| RS2145361853 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2145363966 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS2145364074 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS2145365556 |
EEF2
|
Health Risk |
Likely pathogenic |
— |
| RS2145366125 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145366579 |
NPC1
|
Health Risk |
Likely pathogenic |
Abnormality of metabolism/homeostasis, Abnormality of metabolism/homeostasis |
| RS2145366792 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2145366821 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145366898 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145370503 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145370569 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145370732 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145371777 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145372935 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS2145373524 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145378067 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145378239 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145378635 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS2145381188 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2145381556 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145382111 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2145392365 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS2145393546 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2145393963 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Centronuclear myopathy |
| RS2145394815 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145394955 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145400078 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145400163 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145403032 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2145404496 |
STK11
|
Health Risk |
Pathogenic/Likely pathogenic |
Peutz-Jeghers syndrome, Melanoma |
| RS2145404947 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145405064 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145405118 |
STK11
|
Health Risk |
Pathogenic/Likely pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145405146 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145405165 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145407506 |
LAMA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Laryngo-onycho-cutaneous syndrome, Epidermolysis bullosa |
| RS2145410258 |
BRIP1
|
Health Risk |
Likely pathogenic |
Breast carcinoma, Breast carcinoma |
| RS2145411185 |
RTEL1
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2145411193 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145411302 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145411399 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145411479 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145411718 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145411745 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2145412175 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145412437 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2145412626 |
RTEL1
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2145413226 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145413424 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145413895 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145414039 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145414409 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145414972 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145416923 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2145417422 |
SOX18
|
Health Risk |
Likely pathogenic |
— |
| RS2145417826 |
LAMA3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2145417984 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2145418962 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2145419704 |
GPI
|
Health Risk |
Likely pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS2145420319 |
RTTN
|
Health Risk |
Likely pathogenic |
Microcephaly, Microcephaly |
| RS2145420502 |
STK11
|
Health Risk |
Likely pathogenic |
Generalized juvenile polyposis/juvenile polyposis coli, Generalized juvenile polyposis/juvenile polyposis coli |
| RS2145420680 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145420699 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145420737 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS2145420751 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145420765 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145420792 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145420809 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS2145421181 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145422371 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145422504 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145422531 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS2145422618 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2145422649 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2145422675 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2145423071 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2145423153 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145423487 |
C3
|
Health Risk |
Likely pathogenic |
— |
| RS2145423515 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2145423783 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS2145423903 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145424078 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145424105 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS2145424136 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS2145424188 |
ASXL3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2145424194 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS2145424331 |
STK11
|
Health Risk |
Likely pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145424341 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145424620 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145424635 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145424658 |
STK11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145424662 |
STK11
|
Health Risk |
Likely pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145424716 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145425021 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145425088 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2145425162 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145425286 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2145425465 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2145425479 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2145425576 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |